How many email patterns does IgGenix, Inc use?

IgGenix, Inc uses 2 known email patterns.

What domain does IgGenix, Inc use for work emails?

IgGenix, Inc uses iggenix.com for work email addresses.

Most Common Email Formats at IgGenix, Inc

The most accurate and popular IgGenix, Inc's email format is FLast@iggenix.com (ex. JDoe@iggenix.com). IgGenix, Inc also uses FirstL@iggenix.com (ex. JohnD@iggenix.com) as email structures. IgGenix, Inc uses up to 2 different email patterns.

IgGenix, Inc Email Formats	Example	Percentage
FLast@iggenix.com	JDoe@iggenix.com	67%
FirstL@iggenix.com	JohnD@iggenix.com	33%

Frequently Asked Questions

What does IgGenix, Inc do?

IgGenix, Inc was founded in 2019. operates in the Biotechnology Research industry, along with similar companies like RocheDBV Technologiessanofi. You can visit iggenix.com. Explore IgGenix, Inc's company overview page for more information.

What is IgGenix, Inc's email address format?

IgGenix, Inc's email format typically follows the pattern of FLast@iggenix.com; this email format is used 67% of the time. Other contacts within LeadIQ's database had email formats such as FirstL@iggenix.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does IgGenix, Inc have currently?

IgGenix, Inc has approximately 6 employees as of July 2026. Key team members to contact include Senior Research Associate: E. A.. For more team information and contact data, explore IgGenix, Inc's employee directory with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

IgGenix, Inc Email Format

Biotechnology ResearchCalifornia, United States2-10 Employees

IgGenix, Inc. is a clinical-stage biotechnology company based in South San Francisco, California, focused on developing antibody-based therapies for allergic diseases. It traces its roots to advances from Steve Quake’s laboratory at Stanford, developed in collaboration with allergy clinician and researcher Kari Nadeau. The company operates with a small team, reflecting its early-stage status.

In 2025, IgGenix announced the discovery of a monoclonal antibody for Alpha-gal syndrome and said it would present the work at the AAAAI/WAO Joint Congress. Historically, the company has pursued monoclonal IgG4 antibodies as a therapeutic approach to allergic conditions, including peanut allergy. The intended beneficiaries are patients suffering from allergic diseases and the clinicians who treat them.

Verify IgGenix, Inc email addresses

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Most Common Email Formats at IgGenix, Inc

Frequently Asked Questions

What does IgGenix, Inc do?

What is IgGenix, Inc's email address format?

How many employees does IgGenix, Inc have currently?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

IgGenix, Inc Email Format

Verify IgGenix, Inc email addresses

Ready to create more pipeline?

Ready to create more pipeline?

Everything for prospecting,
in one platform.